The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for subcutaneous Rybrevant Faspro ...

The connection between HPV and oral cancer is becoming clearer. Some population types and risk factors have become closely linked to HPV-associated OSCC. The relationship between HPV-associated OSCC ...

Treatment deintensification for human papillomavirus–positive (HPV+)-associated oropharyngeal cancer (OPC) has been the catalyst of experts worldwide. In situ hybridization is optimal to identify HPV+ ...

PARIS--(BUSINESS WIRE)--TheraVectys, a biotechnology company that designs and develops lentiviral vector-based vaccines and immunotherapies against infectious agents and cancers, announces that the ...

Scientists discovered that rearranging a peptide’s placement in a spherical nucleic acid vaccine dramatically improves immune response against HPV-driven tumors. The findings have the potential to ...